Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Curr Opin Syst Biol. 2017 May 23;5:1–8. doi: 10.1016/j.coisb.2017.05.009

Figure 1. Overview of engineered bacterial cancer therapeutics.

Figure 1

Synthetic biology is capitalizing on bacteria's natural ability to colonize immunoprivileged, hypoxic core regions of tumors through escaping from leaky vasculature. A variety of strategies such as targeting, inducing gene expression, quorum-sensing, expressing and releasing cytotoxics, and intracellular gene delivery have been engineered to control the behavior of these bacteria and produce anti-tumor effects.